secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncorus, Inc. (—)
CIK:        0001671818
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0000950170-23-023023
Event type: debt
Sentiment:  positive
Materiality: 0.65
Item codes: 1.02, 2.04, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Oncorus repays $20M loan with K2 HealthVentures, terminates Loan Agreement; appoints interim CFO
--------------------------------------------------------------------------------

- Repaid $20M principal plus ~$1.6M accrued interest and fees on May 12, 2023; Loan Agreement terminated.
- Alexander Nolte appointed as principal financial officer and accounting officer, serving as interim CFO at $400/hour.
- Mr. Nolte previously VP, Chief Accounting Officer at Syndax Pharmaceuticals; no family relationships disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671818/000095017023023023/0000950170-23-023023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671818/000095017023023023/oncr-20230512.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-023023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer